Industry Research Reports

Home > Reports > Chemical & Material > Imatinib Mesylate- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Imatinib Mesylate- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Chemical & Material

Published Date: 2026-07-14

Pages: 117 Pages

Report ld: 6925191

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Imatinib Mesylate was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.

The North American market for Imatinib Mesylate was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.

The Asia-Pacific market for Imatinib Mesylate was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.

The European market for Imatinib Mesylate was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.

The global key companies in the Imatinib Mesylate market include GLEEVEC, Cayman Chemical, Sichuan Xieli, Zhengda Tianqing, etc. In 2025, the five largest players accounted for approximately % of revenue.

This report provides a comprehensive view of the global market for Imatinib Mesylate, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Imatinib Mesylate market size, estimations, and forecasts are presented in terms of sales volume (MT) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Imatinib Mesylate.

MARKET SEGMENTATION

By Company

GLEEVEC
Cayman Chemical
Sichuan Xieli
Zhengda Tianqing

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

99% Purity
98% Purity
Other

Segment by Application

CML
GIST
Other

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.

Chapter 2: Provides a detailed analysis of the Imatinib Mesylate manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Imatinib Mesylate sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Imatinib Mesylate sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.

Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Imatinib Mesylate Product Introduction

1.2 Global Imatinib Mesylate Market Size Forecast

1.2.1 Global Imatinib Mesylate Sales Value (2021–2032)

1.2.2 Global Imatinib Mesylate Sales Volume (2021–2032)

1.2.3 Global Imatinib Mesylate Sales Price (2021–2032)

1.3 Imatinib Mesylate Market Trends & Drivers

1.3.1 Imatinib Mesylate Industry Trends

1.3.2 Imatinib Mesylate Market Drivers & Opportunities

1.3.3 Imatinib Mesylate Market Challenges

1.3.4 Imatinib Mesylate Market Restraints

1.3.5 Impact of U.S. Tariffs

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Imatinib Mesylate Players Revenue Ranking (2025)

2.2 Global Imatinib Mesylate Revenue by Company (2021–2026)

2.3 Global Imatinib Mesylate Sales Volume Ranking of Players (2025)

2.4 Global Imatinib Mesylate Sales Volume by Company (2021–2026)

2.5 Global Imatinib Mesylate Average Price by Company (2021–2026)

2.6 Key Manufacturers Imatinib Mesylate Manufacturing Base and Headquarters

2.7 Key Manufacturers Imatinib Mesylate Product Offerings

2.8 Key Manufacturers Start of Mass Production of Imatinib Mesylate

2.9 Imatinib Mesylate Market Competitive Analysis

2.9.1 Imatinib Mesylate Market Concentration Rate (2021–2026)

2.9.2 Global 5 and 10 Largest Manufacturers by Imatinib Mesylate Revenue in 2025

2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Imatinib Mesylate revenue, 2025

2.10 Mergers & Acquisitions and Expansion

3 Segmentation Imatinib Mesylate Market Classification

3.1 Introduction by Type

3.1.1 99% Purity

3.1.2 98% Purity

3.1.3 Other

3.1.4 Global Imatinib Mesylate Sales Value by Type

3.1.4.1 Global Imatinib Mesylate Sales Value by Type (2021 vs 2025 vs 2032)

3.1.4.2 Global Imatinib Mesylate Sales Value, by Type (2021–2032)

3.1.4.3 Global Imatinib Mesylate Sales Value, by Type (%), 2021–2032

3.1.5 Global Imatinib Mesylate Sales Volume by Type

3.1.5.1 Global Imatinib Mesylate Sales Volume by Type (2021 vs 2025 vs 2032)

3.1.5.2 Global Imatinib Mesylate Sales Volume, by Type (2021–2032)

3.1.5.3 Global Imatinib Mesylate Sales Volume, by Type (%), 2021–2032

3.1.6 Global Imatinib Mesylate Average Price by Type (2021–2032)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 CML

4.1.2 GIST

4.1.3 Other

4.2 Global Imatinib Mesylate Sales Value by Application

4.2.1 Global Imatinib Mesylate Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Imatinib Mesylate Sales Value, by Application (2021–2032)

4.2.3 Global Imatinib Mesylate Sales Value, by Application (%), 2021–2032

4.3 Global Imatinib Mesylate Sales Volume by Application

4.3.1 Global Imatinib Mesylate Sales Volume by Application (2021 vs 2025 vs 2032)

4.3.2 Global Imatinib Mesylate Sales Volume, by Application (2021–2032)

4.3.3 Global Imatinib Mesylate Sales Volume, by Application (%), 2021–2032

4.4 Global Imatinib Mesylate Average Price by Application (2021–2032)

5 Segmentation by Region

5.1 Global Imatinib Mesylate Sales Value by Region

5.1.1 Global Imatinib Mesylate Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Imatinib Mesylate Sales Value by Region (2021–2026)

5.1.3 Global Imatinib Mesylate Sales Value by Region (2027–2032)

5.1.4 Global Imatinib Mesylate Sales Value by Region (%), 2021–2032

5.2 Global Imatinib Mesylate Sales Volume by Region

5.2.1 Global Imatinib Mesylate Sales Volume by Region: 2021 vs 2025 vs 2032

5.2.2 Global Imatinib Mesylate Sales Volume by Region (2021–2026)

5.2.3 Global Imatinib Mesylate Sales Volume by Region (2027–2032)

5.2.4 Global Imatinib Mesylate Sales Volume by Region (%), 2021–2032

5.3 Global Imatinib Mesylate Average Price by Region (2021–2032)

5.4 North America

5.4.1 North America Imatinib Mesylate Sales Value, 2021–2032

5.4.2 North America Imatinib Mesylate Sales Value by Country (%), 2025 vs 2032

5.5 Europe

5.5.1 Europe Imatinib Mesylate Sales Value, 2021–2032

5.5.2 Europe Imatinib Mesylate Sales Value by Country (%), 2025 vs 2032

5.6 Asia Pacific

5.6.1 Asia Pacific Imatinib Mesylate Sales Value, 2021–2032

5.6.2 Asia Pacific Imatinib Mesylate Sales Value by Region (%), 2025 vs 2032

5.7 South America

5.7.1 South America Imatinib Mesylate Sales Value, 2021–2032

5.7.2 South America Imatinib Mesylate Sales Value by Country (%), 2025 vs 2032

5.8 Middle East & Africa

5.8.1 Middle East & Africa Imatinib Mesylate Sales Value, 2021–2032

5.8.2 Middle East & Africa Imatinib Mesylate Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Imatinib Mesylate Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Imatinib Mesylate Sales Value and Sales Volume

6.2.1 Key Countries/Regions Imatinib Mesylate Sales Value, 2021–2032

6.2.2 Key Countries/Regions Imatinib Mesylate Sales Volume, 2021–2032

6.3 United States

6.3.1 United States Imatinib Mesylate Sales Value, 2021–2032

6.3.2 United States Imatinib Mesylate Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Imatinib Mesylate Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Imatinib Mesylate Sales Value, 2021–2032

6.4.2 Europe Imatinib Mesylate Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Imatinib Mesylate Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Imatinib Mesylate Sales Value, 2021–2032

6.5.2 China Imatinib Mesylate Sales Value by Type (%), 2025 vs 2032

6.5.3 China Imatinib Mesylate Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Imatinib Mesylate Sales Value, 2021–2032

6.6.2 Japan Imatinib Mesylate Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Imatinib Mesylate Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Imatinib Mesylate Sales Value, 2021–2032

6.7.2 South Korea Imatinib Mesylate Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Imatinib Mesylate Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Imatinib Mesylate Sales Value, 2021–2032

6.8.2 Southeast Asia Imatinib Mesylate Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Imatinib Mesylate Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Imatinib Mesylate Sales Value, 2021–2032

6.9.2 India Imatinib Mesylate Sales Value by Type (%), 2025 vs 2032

6.9.3 India Imatinib Mesylate Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 GLEEVEC

7.1.1 GLEEVEC Company Information

7.1.2 GLEEVEC Introduction and Business Overview

7.1.3 GLEEVEC Imatinib Mesylate Sales, Revenue, Price and Gross Margin (2021–2026)

7.1.4 GLEEVEC Imatinib Mesylate Product Offerings

7.1.5 GLEEVEC Recent Developments

7.2 Cayman Chemical

7.2.1 Cayman Chemical Company Information

7.2.2 Cayman Chemical Introduction and Business Overview

7.2.3 Cayman Chemical Imatinib Mesylate Sales, Revenue, Price and Gross Margin (2021–2026)

7.2.4 Cayman Chemical Imatinib Mesylate Product Offerings

7.2.5 Cayman Chemical Recent Developments

7.3 Sichuan Xieli

7.3.1 Sichuan Xieli Company Information

7.3.2 Sichuan Xieli Introduction and Business Overview

7.3.3 Sichuan Xieli Imatinib Mesylate Sales, Revenue, Price and Gross Margin (2021–2026)

7.3.4 Sichuan Xieli Imatinib Mesylate Product Offerings

7.3.5 Sichuan Xieli Recent Developments

7.4 Zhengda Tianqing

7.4.1 Zhengda Tianqing Company Information

7.4.2 Zhengda Tianqing Introduction and Business Overview

7.4.3 Zhengda Tianqing Imatinib Mesylate Sales, Revenue, Price and Gross Margin (2021–2026)

7.4.4 Zhengda Tianqing Imatinib Mesylate Product Offerings

7.4.5 Zhengda Tianqing Recent Developments

8 Industry Chain Analysis

8.1 Imatinib Mesylate Industrial Chain

8.2 Imatinib Mesylate Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customer Analysis)

8.5 Sales Model and Sales Channelss

8.5.1 Imatinib Mesylate Sales Model

8.5.2 Sales Channels

8.5.3 Imatinib Mesylate Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Imatinib Mesylate Market Trends

Table 2. Imatinib Mesylate Market Drivers & Opportunities

Table 3. Imatinib Mesylate Market Challenges

Table 4. Imatinib Mesylate Market Restraints

Table 5. Global Imatinib Mesylate Revenue by Company (US$ Million), 2021–2026

Table 6. Global Imatinib Mesylate Revenue Market Share by Company (2021–2026)

Table 7. Global Imatinib Mesylate Sales Volume by Company (MT), 2021–2026

Table 8. Global Imatinib Mesylate Sales Volume Market Share by Company (2021–2026)

Table 9. Global Market Imatinib Mesylate Price by Company (USD/MT), 2021–2026

Table 10. Key Manufacturers Imatinib Mesylate Manufacturing Base and Headquarters

Table 11. Key Manufacturers Imatinib Mesylate Product Type

Table 12. Key Manufacturers Start of Mass Production of Imatinib Mesylate

Table 13. Global Imatinib Mesylate Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Imatinib Mesylate revenue, 2025

Table 15. Mergers & Acquisitions and Expansion Plans

Table 16. Global Imatinib Mesylate Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 17. Global Imatinib Mesylate Sales Value by Type (US$ Million), 2021–2026

Table 18. Global Imatinib Mesylate Sales Value by Type (US$ Million), 2027–2032

Table 19. Global Imatinib Mesylate Sales Market Share in Value by Type (2021–2026)

Table 20. Global Imatinib Mesylate Sales Market Share in Value by Type (2027–2032)

Table 21. Global Imatinib Mesylate Sales Volume by Type: 2021 vs 2025 vs 2032 (MT)

Table 22. Global Imatinib Mesylate Sales Volume by Type (MT), 2021–2026

Table 23. Global Imatinib Mesylate Sales Volume by Type (MT), 2027–2032

Table 24. Global Imatinib Mesylate Sales Market Share in Volume by Type (2021–2026)

Table 25. Global Imatinib Mesylate Sales Market Share in Volume by Type (2027–2032)

Table 26. Global Imatinib Mesylate Price by Type (USD/MT), 2021–2026

Table 27. Global Imatinib Mesylate Price by Type (USD/MT), 2027–2032

Table 28. Global Imatinib Mesylate Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 29. Global Imatinib Mesylate Sales Value by Application (US$ Million), 2021–2026

Table 30. Global Imatinib Mesylate Sales Value by Application (US$ Million), 2027–2032

Table 31. Global Imatinib Mesylate Sales Market Share in Value by Application (2021–2026)

Table 32. Global Imatinib Mesylate Sales Market Share in Value by Application (2027–2032)

Table 33. Global Imatinib Mesylate Sales Volume by Application: 2021 vs 2025 vs 2032 (MT)

Table 34. Global Imatinib Mesylate Sales Volume by Application (MT), 2021–2026

Table 35. Global Imatinib Mesylate Sales Volume by Application (MT), 2027–2032

Table 36. Global Imatinib Mesylate Sales Market Share in Volume by Application (2021–2026)

Table 37. Global Imatinib Mesylate Sales Market Share in Volume by Application (2027–2032)

Table 38. Global Imatinib Mesylate Price by Application (USD/MT), 2021–2026

Table 39. Global Imatinib Mesylate Price by Application (USD/MT), 2027–2032

Table 40. Global Imatinib Mesylate Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 41. Global Imatinib Mesylate Sales Value by Region (US$ Million), 2021–2026

Table 42. Global Imatinib Mesylate Sales Value by Region (US$ Million), 2027–2032

Table 43. Global Imatinib Mesylate Sales Value by Region (%), 2021–2026

Table 44. Global Imatinib Mesylate Sales Value by Region (%), 2027–2032

Table 45. Global Imatinib Mesylate Sales Volume by Region (MT): 2021 vs 2025 vs 2032

Table 46. Global Imatinib Mesylate Sales Volume by Region (MT), 2021–2026

Table 47. Global Imatinib Mesylate Sales Volume by Region (MT), 2027–2032

Table 48. Global Imatinib Mesylate Sales Volume by Region (%), 2021–2026

Table 49. Global Imatinib Mesylate Sales Volume by Region (%), 2027–2032

Table 50. Global Imatinib Mesylate Average Price by Region (USD/MT), 2021–2026

Table 51. Global Imatinib Mesylate Average Price by Region (USD/MT), 2027–2032

Table 52. Key Countries/Regions Imatinib Mesylate Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 53. Key Countries/Regions Imatinib Mesylate Sales Value, (US$ Million), 2021–2026

Table 54. Key Countries/Regions Imatinib Mesylate Sales Value, (US$ Million), 2027–2032

Table 55. Key Countries/Regions Imatinib Mesylate Sales Volume, (MT), 2021–2026

Table 56. Key Countries/Regions Imatinib Mesylate Sales Volume, (MT), 2027–2032

Table 57. GLEEVEC Company Information

Table 58. GLEEVEC Introduction and Business Overview

Table 59. GLEEVEC Imatinib Mesylate Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)

Table 60. GLEEVEC Imatinib Mesylate Product Offerings

Table 61. GLEEVEC Recent Developments

Table 62. Cayman Chemical Company Information

Table 63. Cayman Chemical Introduction and Business Overview

Table 64. Cayman Chemical Imatinib Mesylate Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)

Table 65. Cayman Chemical Imatinib Mesylate Product Offerings

Table 66. Cayman Chemical Recent Developments

Table 67. Sichuan Xieli Company Information

Table 68. Sichuan Xieli Introduction and Business Overview

Table 69. Sichuan Xieli Imatinib Mesylate Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)

Table 70. Sichuan Xieli Imatinib Mesylate Product Offerings

Table 71. Sichuan Xieli Recent Developments

Table 72. Zhengda Tianqing Company Information

Table 73. Zhengda Tianqing Introduction and Business Overview

Table 74. Zhengda Tianqing Imatinib Mesylate Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)

Table 75. Zhengda Tianqing Imatinib Mesylate Product Offerings

Table 76. Zhengda Tianqing Recent Developments

Table 77. Key Raw Materials Lists

Table 78. Key Suppliers of Raw Materials Lists

Table 79. Imatinib Mesylate Downstream Customers

Table 80. Imatinib Mesylate Distributors List

Table 81. Research Programs/Design for This Report

Table 82. Key Data Information from Secondary Sources

Table 83. Key Data Information from Primary Sources

List of Figures

Figure 1. Imatinib Mesylate Product Picture

Figure 2. Global Imatinib Mesylate Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Imatinib Mesylate Sales Value (US$ Million), 2021–2032

Figure 4. Global Imatinib Mesylate Sales Volume (MT), 2021–2032

Figure 5. Global Imatinib Mesylate Sales Price (USD/MT), 2021–2032

Figure 6. Imatinib Mesylate Report Years Considered

Figure 7. Global Imatinib Mesylate Players Revenue Ranking (US$ Million), 2025

Figure 8. Global Imatinib Mesylate Sales Volume Ranking of Players (MT), 2025

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Imatinib Mesylate Revenue in 2025

Figure 10. Imatinib Mesylate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 11. 99% Purity Picture

Figure 12. 98% Purity Picture

Figure 13. Other Picture

Figure 14. Global Imatinib Mesylate Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Imatinib Mesylate Sales Value Market Share by Type, 2025 & 2032

Figure 16. Global Imatinib Mesylate Sales Volume by Type (MT), 2021 vs 2025 vs 2032

Figure 17. Global Imatinib Mesylate Sales Volume Market Share by Type, 2025 & 2032

Figure 18. Global Imatinib Mesylate Price by Type (USD/MT), 2021–2032

Figure 19. Product Picture of CML

Figure 20. Product Picture of GIST

Figure 21. Product Picture of Other

Figure 22. Global Imatinib Mesylate Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 23. Global Imatinib Mesylate Sales Value Market Share by Application, 2025 & 2032

Figure 24. Global Imatinib Mesylate Sales Volume by Application (MT), 2021 vs 2025 vs 2032

Figure 25. Global Imatinib Mesylate Sales Volume Market Share by Application, 2025 & 2032

Figure 26. Global Imatinib Mesylate Price by Application (USD/MT), 2021–2032

Figure 27. North America Imatinib Mesylate Sales Value (US$ Million), 2021–2032

Figure 28. North America Imatinib Mesylate Sales Value by Country (%), 2025 vs 2032

Figure 29. Europe Imatinib Mesylate Sales Value (US$ Million), 2021–2032

Figure 30. Europe Imatinib Mesylate Sales Value by Country (%), 2025 vs 2032

Figure 31. Asia Pacific Imatinib Mesylate Sales Value (US$ Million), 2021–2032

Figure 32. Asia Pacific Imatinib Mesylate Sales Value by Region (%), 2025 vs 2032

Figure 33. South America Imatinib Mesylate Sales Value (US$ Million), 2021–2032

Figure 34. South America Imatinib Mesylate Sales Value by Country (%), 2025 vs 2032

Figure 35. Middle East & Africa Imatinib Mesylate Sales Value (US$ Million), 2021–2032

Figure 36. Middle East & Africa Imatinib Mesylate Sales Value by Country (%), 2025 vs 2032

Figure 37. Key Countries/Regions Imatinib Mesylate Sales Value (%), 2021–2032

Figure 38. Key Countries/Regions Imatinib Mesylate Sales Volume (%), 2021–2032

Figure 39. United States Imatinib Mesylate Sales Value (US$ Million), 2021–2032

Figure 40. United States Imatinib Mesylate Sales Value by Type (%), 2025 vs 2032

Figure 41. United States Imatinib Mesylate Sales Value by Application (%), 2025 vs 2032

Figure 42. Europe Imatinib Mesylate Sales Value (US$ Million), 2021–2032

Figure 43. Europe Imatinib Mesylate Sales Value by Type (%), 2025 vs 2032

Figure 44. Europe Imatinib Mesylate Sales Value by Application (%), 2025 vs 2032

Figure 45. China Imatinib Mesylate Sales Value (US$ Million), 2021–2032

Figure 46. China Imatinib Mesylate Sales Value by Type (%), 2025 vs 2032

Figure 47. China Imatinib Mesylate Sales Value by Application (%), 2025 vs 2032

Figure 48. Japan Imatinib Mesylate Sales Value (US$ Million), 2021–2032

Figure 49. Japan Imatinib Mesylate Sales Value by Type (%), 2025 vs 2032

Figure 50. Japan Imatinib Mesylate Sales Value by Application (%), 2025 vs 2032

Figure 51. South Korea Imatinib Mesylate Sales Value (US$ Million), 2021–2032

Figure 52. South Korea Imatinib Mesylate Sales Value by Type (%), 2025 vs 2032

Figure 53. South Korea Imatinib Mesylate Sales Value by Application (%), 2025 vs 2032

Figure 54. Southeast Asia Imatinib Mesylate Sales Value (US$ Million), 2021–2032

Figure 55. Southeast Asia Imatinib Mesylate Sales Value by Type (%), 2025 vs 2032

Figure 56. Southeast Asia Imatinib Mesylate Sales Value by Application (%), 2025 vs 2032

Figure 57. India Imatinib Mesylate Sales Value (US$ Million), 2021–2032

Figure 58. India Imatinib Mesylate Sales Value by Type (%), 2025 vs 2032

Figure 59. India Imatinib Mesylate Sales Value by Application (%), 2025 vs 2032

Figure 60. Imatinib Mesylate Industrial Chain

Figure 61. Imatinib Mesylate Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Imatinib Mesylate market? zhanKai

The top companies in the global Imatinib Mesylate market are GLEEVEC、Cayman Chemical、Sichuan Xieli.

Related Reports

Global Imatinib Mesylate Market Research Report 2026
The global Imatinib Mesylate market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-27
Pages: 125
USD 2900.00
(Single User License)
Global Imatinib Mesylate Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Imatinib Mesylate market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 112
USD 4900.00
(Single User License)
Global Imatinib Mesylate Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Imatinib Mesylate market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 75
USD 4250.00
(Single User License)
Imatinib Mesylate- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Imatinib Mesylate was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 80
USD 3950.00
(Single User License)
Global Imatinib Mesylate Market Research Report 2025
The global market for Imatinib Mesylate was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-24
Pages: 83
USD 2900.00
(Single User License)
Global Imatinib Mesylate Market Research Report 2024
The global Imatinib Mesylate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-31
Pages: 91
USD 2900.00
(Single User License)
Imatinib Mesylate - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Imatinib Mesylate was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-24
Pages: 80
USD 3950.00
(Single User License)

Global Imatinib Mesylate Market Research Report 2026
The global Imatinib Mesylate market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-27
Pages: 125
USD 2900.00 (Single User License)
Global Imatinib Mesylate Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Imatinib Mesylate market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 112
USD 4900.00 (Single User License)
Global Imatinib Mesylate Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Imatinib Mesylate market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 75
USD 4250.00 (Single User License)
Imatinib Mesylate- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Imatinib Mesylate was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 80
USD 3950.00 (Single User License)
Global Imatinib Mesylate Market Research Report 2025
The global market for Imatinib Mesylate was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-24
Pages: 83
USD 2900.00 (Single User License)
Global Imatinib Mesylate Market Research Report 2024
The global Imatinib Mesylate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-31
Pages: 91
USD 2900.00 (Single User License)
Imatinib Mesylate - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Imatinib Mesylate was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-24
Pages: 80
USD 3950.00 (Single User License)